secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001628908-25-000008
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health borrows $200M in delayed draw term loans for general corporate purposes
--------------------------------------------------------------------------------

- On Jan 24, 2025, Borrower gave notice to draw $125M (2024-A) and $75M (2024-B) delayed draw term loans, funding Jan 31.
- Proceeds for general corporate purposes including working capital and potential management of Convertible Notes due Oct 2025.
- Interest rate at SOFR+5.50% or base+4.50%, with step-downs based on secured leverage ratio.
- Term loans mature Dec 6, 2029, or earlier upon certain conditions including 180 days before 2029 Convertible Note maturity.
- Prepayment premiums: 2% in year 1, 1% in year 2, 0% thereafter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890825000008/0001628908-25-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890825000008/evh-20250124.htm
  HTML page:      https://secwatch.observer/filing/0001628908-25-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer